Clinical Trial Update: Preoperative Herceptin and Navelbine for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating preoperative Herceptin (trastuzumab) and Navelbine (vinorelbine) for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Navelbine (vinorelbine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer, Stage II Breast Cancer | Phase 2 | Status: COMPLETED